The DGEA Peptide is a peptide with a recognition motif (type I collagen <-> α2β1 integrin) promoting cell adhaesion, spreading, and osteogenic differentiation for bone-healing research. DGEA Peptide Peptide (Uniprot ID: P02452), H-DGEA-OH, from JPT is produced under strict quality control and quality management.
DGEA Peptide - Specifications
- Peptide sequence: H-DGEA-OH
- Amount: 1 mg
- Purity: > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in plastic vial
- Application(s): Bone-healing research
- Standard Delivery Time: approx. 3 weeks
Are you interested in other peptides?Choose sequence, amount and purity. We will assist you along the way:
Custom Peptide SynthesisBone-Healing Peptides from JPT
Bone healing peptides support bone regeneration by acting as signaling molecules. They bind to cell receptors and activate pathways involved in bone growth and repair. This increases osteoblast differentiation, improves cell adhesion, and enhances the formation of new bone tissue. Some peptides also promote blood vessel formation and reduce inflammation. Their ability to mimic natural growth factors and hormones makes them effective targeting tools in orthopedic research, tissue engineering, and regenerative medicine.
Benefits of JPT’s BoneHealing Peptides
- Each peptide quality controlled and guaranteed for identity and purity
- CoA and HPLC-MS data available
- High batch-to-batch consistency
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
